Publicacions en col·laboració amb investigadors/es de Hospital Universitario La Paz (62)

2020

  1. Drug development for noise-induced hearing loss

    Expert Opinion on Drug Discovery, Vol. 15, Núm. 12, pp. 1457-1471

2019

  1. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia–Reperfusion Injury in Mice

    Hepatology, Vol. 70, Núm. 2, pp. 650-665

2017

  1. A comparative study of drug delivery methods targeted to the mouse inner ear: Bullostomy Versus transtympanic injection

    Journal of Visualized Experiments, Vol. 2017, Núm. 121

  2. Metamizole (dipyrone) effects on sevoflurane requirements and postoperative hyperalgesia in rats

    Laboratory Animals, Vol. 51, Núm. 4, pp. 365-375

2016

  1. Effect of lidocaine-ketamine infusions combined with morphine or fentanyl in sevoflurane-anesthetized pigs

    Journal of the American Association for Laboratory Animal Science, Vol. 55, Núm. 3, pp. 317-320

  2. Neonatal pneumothorax pressures surpass higher threshold in lung recruitment maneuvers: An in vivo interventional study

    Respiratory Care, Vol. 61, Núm. 2, pp. 142-148

  3. The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane's Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats

    Anesthesia and Analgesia, Vol. 122, Núm. 5, pp. 1370-1376

2014

  1. Treatment with N- And C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice

    PLoS ONE, Vol. 9, Núm. 2

2013

  1. Effects of naloxone on opioid-induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats

    Anesthesiology, Vol. 118, Núm. 5, pp. 1160-1169

2012

  1. NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis

    PLoS ONE, Vol. 7, Núm. 9

  2. Reduction of the sevoflurane minimum alveolar concentration induced by methadone, tramadol, butorphanol and morphine in rats

    Laboratory Animals, Vol. 46, Núm. 3, pp. 200-206

  3. The effects of gabapentin on acute opioid tolerance to remifentanil under sevoflurane anesthesia in rats

    Anesthesia and Analgesia, Vol. 115, Núm. 1, pp. 40-45

2011

  1. Ketamine and remifentanil interactions on the sevoflurane minimum alveolar concentration and acute opioid tolerance in the rat

    Anesthesia and Analgesia, Vol. 113, Núm. 3, pp. 505-512

  2. The role of insulin-like growth factor-i in the physiopathology of hearing

    Frontiers in Molecular Neuroscience, Vol. 4

2010

  1. Exogenous ghrelin regulates proliferation and apoptosis in the hypotrophic gut mucosa of the rat

    Experimental Biology and Medicine, Vol. 235, Núm. 4, pp. 463-469

  2. Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat

    British Journal of Anaesthesia, Vol. 105, Núm. 6, pp. 810-817

2009

  1. Analgesic and motor-blocking action of epidurally administered levobupivacaine or bupivacaine in the conscious dog

    Veterinary Anaesthesia and Analgesia, Vol. 36, Núm. 5, pp. 485-494

  2. Determination of the minimum alveolar concentration for halothane, isoflurane and sevoflurane in the gerbil

    Laboratory Animals, Vol. 43, Núm. 3, pp. 239-242

  3. Opioid tolerance blunts the reduction in the swevoflurane minimum alveolar concentration produced by remifentanil in the rat

    Anesthesiology, Vol. 110, Núm. 5, pp. 1133-1138

2007

  1. Acciones neurotróficas del factor de crecimiento similar a la insulina de tipo I en el oído interno

    Revista de Neurologia, Vol. 45, Núm. 4, pp. 245-250